Accuray Inc (ARAY)
2.13
-0.06
(-2.74%)
USD |
NASDAQ |
Jan 08, 16:00
2.14
+0.01
(+0.47%)
Pre-Market: 20:00
Accuray SG&A Expense (Quarterly): 24.50M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Baxter International Inc | 754.00M |
| Boston Scientific Corp | 1.562B |
| Haemonetics Corp | 106.95M |
| Perspective Therapeutics Inc | 6.975M |
| Xtant Medical Holdings Inc | 19.38M |